Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

UBX

Unity Biotechnology, Inc.

Biotechnology firm, Unity Biotechnology, Inc., has established itself as a crucial player in the fight against aging-related diseases. Through its robust research and development program, Unity Bio...

Unity Biotechnology, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

CLRB

Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc., a prominent clinical biopharmaceutical firm, announced its mission to revolutionize cancer treatment by pioneering the discovery, development, and commercialization of ...

Cellectar Biosciences, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

XBIO

Xenetic Biosciences, Inc.

Xenetic Biosciences is honing in on the revolutionary XCART technology, a personalized chimeric antigen receptor T cell (CAR T) platform designed to specifically target patient-specific tumor neoan...

Xenetic Biosciences, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

OSMT

Osmotica Pharmaceuticals plc

Osmotica Pharmaceuticals plc is a biopharmaceutical company dedicated to developing and selling specialty products in the neurology and women's health space, as well as non-promoted complex formula...

Osmotica Pharmaceuticals plc Annual Report 2021

Healthcare Biotechnology NASDAQ 201-500

CSL

CSL

Carlisle Companies Incorporated, a manufacturer of engineered products, operates across multiple regions globally, including the United States, Europe, Asia, Mexico, and the United Kingdom. The com...

CSL Annual Report 2023

Healthcare Biotechnology ASX 10,000+

INMB

INmune Bio

Clinical-stage immunology company INmune Bio is stepping up efforts to reprogram the innate immune system for cancer and neurodegenerative disease treatment through the development and commercializ...

INmune Bio Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

FGEN

FibroGen

Biopharmaceutical company FibroGen, Inc. is a leading player in discovering, developing, and commercializing therapeutics aimed to address serious unmet medical needs. With a focus on its lead prod...

FibroGen Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

RGS

Regis

Regis Corporation, the well-known hairstyling giant, is making waves around the world, with its impressive presence in the United States, Canada, Puerto Rico, and the United Kingdom. As a pioneer i...

Regis Annual Report 2021

Healthcare Biotechnology ASX 11-50

NFX

Nuformix plc

Nuformix plc is a UK-based pharmaceutical development company that specializes in treating fibrosis and oncology through drug repurposing. The company's main programs include NXP001, which is in th...

Nuformix plc Annual Report 2023

Healthcare Biotechnology LSE 1-10

VRCA

Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc., an innovative clinical-stage dermatology therapeutics company, based in West Chester, Pennsylvania, is making strong progress in developing groundbreaking medications ...

Verrica Pharmaceuticals Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

ALPN

Alpine Immune Sciences

Seattle-based Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical firm that specializes in researching and developing protein-based immunotherapies to treat diseases such as cancer a...

Alpine Immune Sciences Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

CNSP

CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, a Houston-based clinical pharmaceutical firm, is focused on the development of novel anti-cancer drug candidates targeting central nervous system tumors. Their lead candidate, ...

CNS Pharmaceuticals, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

BGNE

BeiGene, Ltd.

BeiGene, Ltd., a global biotechnology firm, is making impressive strides in the field of oncology medicine. The company's array of products includes BRUKINSA, a treatment for various blood cancers,...

BeiGene, Ltd. Annual Report 2023

Healthcare Biotechnology NASDAQ 1001-5000

AGLE

Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, a company specializing in clinical-stage biotechnology, is making waves in the realm of rare metabolic disease treatment. They have developed groundbreaking human enzyme the...

Aeglea BioTherapeutics, Inc. Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

ADVM

Adverum Biotechnologies, Inc.

Adverum Biotechnologies, a clinical-stage biotechnology company, is focused on developing groundbreaking gene therapy product candidates to treat ocular and rare diseases. The company's main produc...

Adverum Biotechnologies, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200